Go Pro
NASDAQ:YDES

YD Bio (YDES) Stock Price, News & Analysis

YD Bio logo
$2.51 +0.21 (+9.13%)
As of 03:59 PM Eastern

About YD Bio Stock (NASDAQ:YDES)

Advanced

Key Stats

Today's Range
$2.17
$2.57
50-Day Range
$1.90
$3.61
52-Week Range
$1.70
$25.00
Volume
35,050 shs
Average Volume
38,391 shs
Market Capitalization
$177.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

YD Bio Limited is a biotechnology company focused on the development of DNA methylation-based cancer detection technologies and ophthalmologic innovations. The company also provides clinical trial support and related research services.

YD Bio Limited is headquartered in Taipei, Taiwan, and its ordinary shares trade on the Nasdaq Global Market under the ticker symbol YDES.

Receive YDES Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for YD Bio and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

YDES Stock News Headlines

Trump's Next Move Could Shrink Your Dollar
There's a plan in Washington being called the 'Mar-a-Lago Accord' - a deliberate strategy to weaken the U.S. dollar through tariffs, currency pressure, and coordinated policy shifts designed to boost American exports. A weaker dollar means every dollar you've saved buys less - quietly, without a headline or a warning. Smart investors are already repositioning before the slide accelerates.tc pixel
YD Bio Limited
YD Bio Ltd.
See More Headlines

YDES Stock Analysis - Frequently Asked Questions

YD Bio's stock was trading at $12.19 at the start of the year. Since then, YDES shares have decreased by 79.4% and is now trading at $2.51.

Shares of YDES stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/10/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:YDES
CIK
2011674
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
2025

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
70,790,000
Free Float
N/A
Market Cap
$177.68 million
Optionable
N/A
Beta
N/A

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:YDES) was last updated on 8/10/2026 by MarketBeat.com Staff.
From Our Partners